doxycycline hyclate 50 MG Delayed Release Oral Tablet

RxCUI
1653433
RxNorm name
doxycycline hyclate 50 MG Delayed Release Oral Tablet
Display name
Doxycycline (Oral Pill)
Full name
doxycycline hyclate 50 MG Delayed Release Oral Tablet
Term type
SCD
Status
Active
Strength
50 mg
Dose form
DR Tab
Route
Oral Pill
Updated
2026-11-12 18:37:15

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072015
Active start
072015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
doxycycline hyclate50 MG / 1 EACHdoxycyclinedoxycycline

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Delayed Release Oral Tablet10312

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
doxycycline3640

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdoxycycline hyclate 50 MG Delayed Release Oral Tablet1NAMES
RxNorm Namedoxycycline hyclate 50 MG Delayed Release Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI16534331CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0591-4550-220591-4550Doxycycline Hyclate Doxycycline HyclateActavis Pharma, Inc.ANDA090134
43547-462-1243547-462DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATESolco Healthcare US LLCANDA207494

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA0901340591-4550Doxycycline Hyclate Doxycycline HyclateANDAActavis Pharma, Inc.
ANDA20749443547-462DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATEANDASolco Healthcare US LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00591455022rxnav_ndcsyes
43547046212rxnav_ndcsyes
51862070912rxnav_ndcsyes
00378453505rxnav_historical
00378453578rxnav_historical
00378453591rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DOXYCYCLINE HYCLATEDOXYCYCLINE HYCLATESolco Healthcare US LLC0a18d4c7-9484-4d3e-b61b-e81fe63fefec2025-10-31Warnings, Adverse reactionsExact identifier
ndc (package): 43547-462-12
ndc (product): 43547-462
ndc11 (package): 43547046212
rxcui: 1653433
Doxycycline HyclateDOXYCYCLINE HYCLATEActavis Pharma, Inc.c2b08332-3256-4658-965a-ede3d973a3882025-04-01Warnings, Adverse reactionsExact identifier
ndc (package): 0591-4550-22
ndc (product): 0591-4550
ndc11 (package): 00591455022
rxcui: 1653433

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c2b08332-3256-4658-965a-ede3d973a388doxycycline hyclate 50 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 50 MG Delayed Release Oral Tablet [SCD]28These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 196720250401
0a18d4c7-9484-4d3e-b61b-e81fe63fefecdoxycycline hyclate 50 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 50 MG Delayed Release Oral Tablet [SCD]27These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 196720251031

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20251031
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20251031
f9c63af9-d613-43fc-b8e5-ab6219f24c70These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Mayne Pharma Commercial LLC | Mayne Pharma International Pty Ltd | Catalent Greenville, Inc.20250414
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20220922
0c01acd6-123b-43f3-b639-b039e83baa27These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS . DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Mylan Pharmaceuticals Inc.20200226
2e9d34a2-8173-4202-8187-3994bd8a9e1dThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Mylan Pharmaceuticals Inc.20170130

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4doxycycline
ATCJ01AATetracyclinesATC1-4doxycycline
FDASPLD013754TetracyclinesCHEMhas_chemical_structuredoxycycline
FDASPLN0000175882Tetracycline-class DrugEPChas_epcdoxycycline
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline hyclate
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline
MEDRTD002771CholeraDISEASEmay_treatdoxycycline hyclate
MEDRTD002771CholeraDISEASEmay_treatdoxycycline
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline hyclate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline hyclate
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD010930PlagueDISEASEmay_treatdoxycycline
MEDRTD010930PlagueDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline hyclate
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline
MEDRTD011247PregnancyDISEASEci_withdoxycycline hyclate
MEDRTD011247PregnancyDISEASEci_withdoxycycline
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline hyclate
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline hyclate
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline hyclate
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline hyclate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH50 MG (expressed as doxycycline hyclate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA090134
CODESANDAANDA207494
CODESVUID4034510
NAMESPrescribable Synonymdoxycycline hyclate 50 MG Delayed Release Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File